VTRS
Viatris Inc
Key Financials
Gross Profit
$5.0B
↓ 10.8%
Net Income
$0
N/A
Operating Income
$-2663100000
↓ 26467.3%
Revenue
$14.3B
↓ 3.0%
EPS (Diluted)
$-3.00
↓ 466.0%
Total Assets
$37.2B
↓ 10.4%
Cash & Equivalents
$1.3B
↑ 80.0%
Shareholders' Equity
$0.00
NaN%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/16/2026 | View on SEC |
| ARS | 4/2/2026 | View on SEC |
| DEFA14A | 4/2/2026 | View on SEC |
| DEF 14A | 4/2/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| 4 | 3/24/2026 | View on SEC |
| 144 | 3/23/2026 | View on SEC |
| 4 | 3/10/2026 | View on SEC |
| 4 | 3/10/2026 | View on SEC |
| 4 | 3/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VTRS |
| Company Name | Viatris Inc |
| CIK | 1792044 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (724) 514-1465 |